期刊文献+

糖尿病大鼠甲状腺组织RAGE mRNA和蛋白表达的变化 被引量:5

Changes of RAGE mRNA and Protein Expression in Thyroid of Diabetic Mellitus Rats
下载PDF
导出
摘要 目的:探讨糖尿病(DM)大鼠甲状腺组织终末糖基化产物受体(RAGE)mRNA和蛋白的表达水平及其与血糖的关系。方法:经高脂饲料喂养联合注射小剂量链脲佐菌素制备DM大鼠49只,随机分为DM组(17只)、胰岛素干预组(DI组,16只)、氨基胍干预组(DA组,16只),另设正常对照组(NC组,9只)。成模12周末测空腹血糖后,经股动脉放血处死大鼠。取甲状腺组织,分别以GAPDH和β-actin作为内对照,用半定量RT-PCR和WesternBlot方法测定各组RAGEmRNA和蛋白的表达。结果:DM组大鼠血糖为(31.72±9.29)mmol/L、甲状腺组织RAGE mRNA与GAPDH mRNA表达比为0.90±0.30,RAGE蛋白与β-actin蛋白表达比为0.88±0.23,均高于NC组的(4.87±0.75)mmol/L、0.27±0.17和0.44±0.21,差别有统计学意义(均P<0.05),DI组与DA组大鼠甲状腺组织RAGEmRNA和蛋白表达分别为0.60±0.22、0.67±0.27和0.38±0.20、0.45±0.17,均低于DM组(均P<0.05)。结论:DM大鼠甲状腺组织RAGE mRNA和蛋白表达增高;积极地控制血糖、阻断终末糖基化产物的形成有利于抑制甲状腺组织RAGE高表达。 Objective:To investigate the expression of receptor for advanced glycation end products (RAGE) in the thyroid tissue of diabetes mellitus (DM) rats.Methods:The rat model of DM was established by high-lipid diet and vena caudalis injection of streptozocin.The rats of DM models were then randomly divided into three groups:DM group(n=17),insulin intervention group(n=16) and aminoguanidine intervention group (n=16).Nine normal rats were taken as controls.Twelve weeks after the establishment of DM model,rats were sacrificed and the thyroid tissue was taken to determine RAGE mRNA and the protein expression with the method of RT-PCR and Western Blot.Results:The levels of RAGE mRNA and protein expression were higher in the thyroid tissue of DM rats than those in controls (P 0.05).The levels of RAGE mRNA and protein expression were lower in the thyroid tissue of insulin intervention group and aminoguanidine intervention group than those of DM group (P 0.05).Conclusion:The levels of RAGE mRNA and protein expression were up-regulated in the thyroid tissue of DM rats,which can be restrained by controlling blood glucose and blocking the formation of advanced glycation end products.
出处 《天津医药》 CAS 北大核心 2010年第2期118-120,共3页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(项目编号:30670992) 天津市自然科学基金资助项目(项目编号:06YFJMJC07800)
关键词 糖尿病 2型 甲状腺 胰岛素 胍类 糖基化终产物 高级 大鼠 Wistar diabetes mellitus type 2 thyroid gland insulin guanidines glyosylation end products advanced rats Wistar
  • 相关文献

参考文献3

二级参考文献17

  • 1张宏,卢军,赵伟,郑凝,谢云,张秋梅,董如娇,方佩华.T2DM合并甲状腺肿患者心血管疾病患病情况的初步探讨[J].天津医科大学学报,2005,11(3):423-425. 被引量:11
  • 2张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量:40
  • 3张宏,方佩华,郑凝,常宝成,赵伟,董如娇,王家驰.住院2型糖尿病患者甲状腺功能状态的分析[J].国际内分泌代谢杂志,2007,27(2):139-141. 被引量:79
  • 4Menon PS, Vaidyanathan B, Kaur M. Autoimnlune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab, 2001,14(3): 279-286.
  • 5Bestteti GE.One month of streptozotocin-diabetes induce different neuroendocrine and morphological alterations in the hypothalamus-pituitary axix of male and female rats. Endocrinology,1985,117:208-216
  • 6Vondra K,Vrbikova J, Dvorakova K. Thyroid gland diseases in adult patients with diabetes mellitus [J]. Minerva Endocrinol, 2005,30:217-236.
  • 7Amano S,Kaji Y,Oshika T,et al. Advanced glycation end products in human optic nerve head[J]. Br J Ophthalmol, 2001,85 : 52-55.
  • 8Pimenta WP, Mazeto GM, Callegaro CF, et al. Thyroid disorders in diabetic patients [J]. Arq Bras Endocrinol Metabol, 2005,49:234- 240.
  • 9Hansen D, Bennedbaek FN, Hoier-Madson M, et al. A prospective study of thyroid function,morphology and autoimmunity in young patients with type 1 diabetes [J]. Eur J Endocrinol, 2003,148 : 245- 251.
  • 10Niwa T. Dialysis-related amyloidosis:pathogenesis focusing on AGE modification[J]. Semin Dial, 2001,14:123-126.

共引文献50

同被引文献53

  • 1张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量:40
  • 2LU Lin ZHANG Qi PU Li-jin XU Xue-wei ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zheng-kun LU An-kang DING Feng-hua SHEN Jie CHEN Qiu-jin LOU Sheng FANG Dan-hong SHEN Wei-feng.Elevation of tumor necrosis factor-α,interleukin-1β and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes[J].Chinese Medical Journal,2007(6):479-484. 被引量:43
  • 3韩宝玲,韩静,张凤平.妊娠糖尿病患者胰岛素抵抗的临床探讨[J].实用糖尿病杂志,2007,3(3):15-16. 被引量:8
  • 4Kordonouri O, Klinghammer A, Lang EB, et al. Thyroid autoimmu- nity in children and adolescents with type 1 diabetes:a muhicenter survey[ J~. Diabetes Care ,2002,25 ( 8 ) : 1346-1350.
  • 5Barova H, Perusicova J, Hill M, et al. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus [ J ]. Physiol Res,2004,53 (3) :279-286.
  • 6Kawasaki E, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease[ J]. Diabetes, 1994,43 ( 1 ) :80-$6.
  • 7Yamagishi S, Matsui T, Nakamura K. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes [ J ]. Curr Drug Target, 2007,8(10) :1138-1143.
  • 8Ramasamy R, Vannucci S J, Yah SS, et al. Advanced glycation end products and RAGE:a common thread in aging, diabetes, neurode- generation, and inflammation [ J]. Glycobiology ,2005 , 15 (7) : 16R- 28R.
  • 9Tian L, Gao C, Liu J, et al. Increased carotid arterial stiffness in subclinical hypothyroidism[ J ]. Eur J Intern Med, 2010,21 ( 6 ) : 560-563.
  • 10Mikhail GS, Alshammari SM, Alenezi MY, et al. Increased athero- genic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism [ J ]. Endocr Pract, 2008,14 ( 5 ) :570 -575.

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部